These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 27147201)

  • 1. Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected].
    Ma L; Song Y; Li C; Wang E; Zheng D; Qu F; Zhou J
    Climacteric; 2016 Aug; 19(4):400-5. PubMed ID: 27147201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone turnover markers and bone density across the menopausal transition.
    Ebeling PR; Atley LM; Guthrie JR; Burger HG; Dennerstein L; Hopper JL; Wark JD
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3366-71. PubMed ID: 8784098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J; Wallaschofski H; Friedrich N; Spielhagen C; Rettig R; Ittermann T; Nauck M; Hannemann A
    Bone; 2013 Dec; 57(2):399-404. PubMed ID: 24076251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of serum FSH measurement on bone resorption in postmenopausal women.
    García-Martín A; Reyes-García R; García-Castro JM; Rozas-Moreno P; Escobar-Jiménez F; Muñoz-Torres M
    Endocrine; 2012 Apr; 41(2):302-8. PubMed ID: 21964645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.
    Li M; Li Y; Deng W; Zhang Z; Deng Z; Hu Y; Xia W; Xu L
    PLoS One; 2014; 9(8):e103841. PubMed ID: 25117452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized placebo-controlled trial of short-term graded transdermal estradiol in healthy gonadotropin-releasing hormone agonist-suppressed pre- and postmenopausal women: effects on serum markers of bone turnover, insulin-like growth factor-I, and osteoclastogenic mediators.
    Liu PY; Hoey KA; Mielke KL; Veldhuis JD; Khosla S
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1953-60. PubMed ID: 15623811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women.
    Wu XY; Wu XP; Xie H; Zhang H; Peng YQ; Yuan LQ; Su X; Luo XH; Liao EY
    Osteoporos Int; 2010 Feb; 21(2):275-85. PubMed ID: 19562242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
    Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
    Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone turnover across the menopause transition: correlations with inhibins and follicle-stimulating hormone.
    Perrien DS; Achenbach SJ; Bledsoe SE; Walser B; Suva LJ; Khosla S; Gaddy D
    J Clin Endocrinol Metab; 2006 May; 91(5):1848-54. PubMed ID: 16449331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
    Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
    Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of bone turnover markers in healthy premenopausal women.
    Adami S; Bianchi G; Brandi ML; Giannini S; Ortolani S; DiMunno O; Frediani B; Rossini M;
    Calcif Tissue Int; 2008 May; 82(5):341-7. PubMed ID: 18470550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserved postprandial suppression of bone turnover markers, despite increased fasting levels, in postmenopausal women.
    Abildgaard J; Ploug T; Pedersen AT; Eiken P; Pedersen BK; Holst JJ; Hartmann B; Lindegaard B
    Bone; 2021 Feb; 143():115612. PubMed ID: 32853851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of sex hormones and parathyroid hormone with biochemical markers of bone turnover in aged men].
    Xiao HY; Lu YH; Gong YP; Pei Y; Cheng XL; Li N; Fang FS; Tian H; Li CL
    Zhonghua Nan Ke Xue; 2014 Mar; 20(3):257-62. PubMed ID: 24738465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN.
    Sowers MR; Greendale GA; Bondarenko I; Finkelstein JS; Cauley JA; Neer RM; Ettinger B
    Osteoporos Int; 2003 May; 14(3):191-7. PubMed ID: 12730778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
    Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
    J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of neoadjuvant chemotherapy on the serum levels of bone turnover markers in women with early-stage breast cancer.
    Chen Y; Xu G; Yang F
    PLoS One; 2015; 10(4):e0126053. PubMed ID: 25923354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between insulin-like growth factor I and bone turnover markers in the general adult population.
    Niemann I; Hannemann A; Nauck M; Spielhagen C; Völzke H; Wallaschofski H; Friedrich N
    Bone; 2013 Sep; 56(1):184-90. PubMed ID: 23792936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women's Health Initiative.
    Crandall CJ; Vasan S; LaCroix A; LeBoff MS; Cauley JA; Robbins JA; Jackson RD; Bauer DC
    J Bone Miner Res; 2018 Jul; 33(7):1199-1208. PubMed ID: 29923225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.